GLP-1s, such as Type 2 diabetes therapies Ozempic and Mounjaro and weight loss drug Wegovy, are expected to bulk up the U.S. economy as more Americans shed pounds.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Weight loss drugs wrinkle economies worldwide
